Targeting Glioma Stem Cells by Functional Inhibition of Dynamin 2: A Novel Treatment Strategy for Glioblastoma.

Abstract:

:Glioma stem cells (GSCs) play major roles in drug resistance, tumour maintenance and recurrence of glioblastoma. We investigated inhibition of the GTPase dynamin 2 as a therapy for glioblastoma. Glioma cell lines and patient-derived GSCs were treated with dynamin inhibitors, Dynole 34-2 and CyDyn 4-36. We studied about cell viability, and GSC neurosphere formation in vitro and orthotopic tumour growth in vivo. Dynamin inhibition reduced glioblastoma cell line viability and suppressed neurosphere formation and migration of GSCs. Tumour growth was reduced by CyDyn 4-36 treatment. Dynamin 2 inhibition therefore represents a novel approach for stem cell-directed Glioblastoma therapy.

journal_name

Cancer Invest

journal_title

Cancer investigation

authors

Luwor R,Morokoff AP,Amiridis S,D'Abaco G,Paradiso L,Stylli SS,Nguyen HPT,Tarleton M,Young KA,O'Brien TJ,Robinson PJ,Chircop M,McCluskey A,Jones NC

doi

10.1080/07357907.2019.1582060

subject

Has Abstract

pub_date

2019-01-01 00:00:00

pages

144-155

issue

3

eissn

0735-7907

issn

1532-4192

journal_volume

37

pub_type

杂志文章
  • Heterogeneity in TPA-induced differentiation of B-chronic lymphocytic leukemia cells: development of hairy cell or plasmacytoid features are time and dose dependent.

    abstract::Cells from 11 chronic lymphocytic leukemic (CLL) patients were induced to differentiate with various doses of tetradecanoyl phorbol-13-acetate (TPA) and the degree of induction was followed up to six days by measuring the expression of two surface membrane markers (SmIg and GP-70), Ig secretion, tartrate-resistant aci...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:

    authors: Gazitt Y,Gurfel D,Leizerowitz R,Feinstein H,Polliack A

    更新日期:1987-01-01 00:00:00

  • Predictors of Interventional Treatment Use for Venous Thromboembolism in Cancer Patients.

    abstract::Venous thromboembolic disease is a major cause of morbidity in cancer patients. The Perspective database was used to identify patients with solid tumors and a diagnosis of VTE from 2006 to 2012. We examined use of IVC filters, thrombolysis, and thrombectomy. Among 32,545 patients, 23.1% received an IVC filter, 1.9% th...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357907.2016.1221078

    authors: Yoon L,Clarke Hillyer G,Chen L,Hu JC,Neugut AI,Hershman DL,Wright JD

    更新日期:2016-09-13 00:00:00

  • Current update of cytokines in pancreatic cancer: pathogenic mechanisms, clinical indication, and therapeutic values.

    abstract::Pancreatic cancer is the fourth leading cause of cancer death with a 5-year survival less than 5 percent despite rigorous interventions. This largely is due to its late presentation, aggressive metastasis, and a lack of effective adjuvant therapies. Cytokines have been studied in many tumor types, where they have been...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1080/07357900600981398

    authors: Feurino LW,Fisher WE,Bharadwaj U,Yao Q,Chen C,Li M

    更新日期:2006-11-01 00:00:00

  • Antitumor activity and apoptosis induction in human cancer cell lines by Dionysia termeana.

    abstract::Studies have demonstrated that plant extracts possess various biological effects including antitumor activity. In the present study, the antitumor activity of Dionysia termeana, a plant native to Iran, was investigated. Cytotoxic activity of the extract on tumor cell lines using MTT colorimetric assay was determined. ...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900701518487

    authors: Amirghofran Z,Bahmani M,Azadmehr A,Ashouri E,Javidnia K

    更新日期:2007-10-01 00:00:00

  • Long-term effects on the intelligence of children treated for acute lymphoblastic leukemia.

    abstract::The purpose of this study was to investigate whether the intelligence quotient (IQ) in children treated for leukemia decreases in the years following whole brain irradiation. Twenty-seven leukemic children were assessed following a mean time lapse between radiotherapy and IQ measurement of 9 years. The IQ test used wa...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1081/cnv-100104285

    authors: Kolotas C,Daniel M,Demetriou L,Martin T,Kurek R,Tonus C,Göbel U,Schnabel T,Zamboglou N

    更新日期:2001-01-01 00:00:00

  • Papilloma and polyoma DNA tumor virus sequences in female genital tumors.

    abstract::Human papillomaviruses (HPVs) and BKV, JCV, and SV40 polyomaviruses (PYVs) are oncogenic viruses associated with different human tumors. Our aim was to determine if PYV and HPV sequences could be detected in human genital tumors. HPV types 6b, 11, 16, and 18 and PYV were investigated in 22 genital tumor samples and th...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1081/cnv-200032937

    authors: Martini F,Iaccheri L,Martinelli M,Martinello R,Grandi E,Mollica G,Tognon M

    更新日期:2004-01-01 00:00:00

  • Infusional mitoxantrone plus bolus melphalan as a stem cell transplant conditioning regimen for multiple myeloma.

    abstract::This study combined infusional mitoxantrone with bolus melphalan as a transplant preparative regimen for multiple myeloma. Mitoxantrone was infused over 6 hr on days 6 and 5. Melphalan was given as a 15 min bolus on day 1 followed by autologous transplant on day 0. Thirty-five patients were enrolled; 57% of enrollees ...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2010.550663

    authors: Beaven AW,Moore DT,Sharf A,Serody JS,Shea TC,Gabriel DA

    更新日期:2011-03-01 00:00:00

  • ErbB receptors as prognostic and therapeutic drug targets in bone and soft tissue sarcomas.

    abstract::ErbB receptors have been intensely studied to understand their importance in cancer biology and as therapeutic targets, and many ErbB inhibitors are now used in the clinical setting. A large number of studies have been conducted to examine the expression of ErbB family members in bone and soft tissue sarcomas, includi...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.3109/07357907.2014.964409

    authors: Wang H,Yang Q,Fu Z,Zuo D,Hua Y,Cai Z

    更新日期:2014-12-01 00:00:00

  • Vinorelbine (Navelbine): a third-generation vinca alkaloid.

    abstract::The vinca alkaloids represent one of the oldest classes of antineoplastic agents used in humans with a wide spectrum of activity against both animal and human tumors. These agents are known to inhibit microtubule polymerization. Vinorelbine is a semisynthetic analog that reached clinical trial on the basis of less pre...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.3109/07357909709047587

    authors: Budman DR

    更新日期:1997-01-01 00:00:00

  • Improved response by co-targeting EGFR/EGFRvIII and Src family kinases in human cancer cells.

    abstract::We hypothesized that co-targeting the epidermal growth factor receptor (EGFR) and Src with the EGFR inhibitor gefitinib and the Src inhibitor AZD0530 would increase growth inhibition and impede migration. Cells overexpressing EGFR were more sensitive to gefitinib than cells expressing mutated EGFR or normal levels of ...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900802570759

    authors: Andersen P,Villingshøj M,Poulsen HS,Stockhausen MT

    更新日期:2009-02-01 00:00:00

  • Novel Quinoxaline-2-Carbonitrile-1,4-Dioxide Derivatives Suppress HIF1α Activity and Circumvent MDR in Cancer Cells.

    abstract::A series of 3-aryl/hetarylquinoxaline-2-carbonitrile-1,4-dioxides was synthesized and evaluated against breast cancer cell lines in normoxia and hypoxia. Selected compounds in this series demonstrated better cytotoxicity and comparable hypoxia selectivity than tirapazamine. In contrast to Dox, quinoxaline-1,4-dioxides...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357907.2018.1453072

    authors: Scherbakov AM,Borunov AM,Buravchenko GI,Andreeva OE,Kudryavtsev IA,Dezhenkova LG,Shchekotikhin AE

    更新日期:2018-03-16 00:00:00

  • 5-Aza-2'-deoxycytidine restores proapoptotic function of p53 in cancer cells resistant to p53-induced apoptosis.

    abstract::The expression of p53-target genes encoding the proapoptotic factor Noxa, but not PUMA, was not induced by p53 in HCT116 and SW480 cells, which show resistance to apoptosis in response to p53 overexpression. The lack of p53 inducibility of Noxa was restored by treatment with the DNA methyltransferase inhibitor 5-Aza-2...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900701840212

    authors: Yagi S,Oda-Sato E,Uehara I,Asano Y,Nakajima W,Takeshita T,Tanaka N

    更新日期:2008-08-01 00:00:00

  • Thrombin expression in prostate: a novel finding.

    abstract:INTRODUCTION:A variable repertoire of coagulation protein expression is observed in different cancers. We evaluated expression of thrombin in prostate tissue. METHODS:Detection of thrombin was performed using quantitative real-time PCR in fresh tissue and in situ hybridization (ISH) in archival prostate tissue and by ...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2010.535057

    authors: Kohli M,Williams K,Yao JL,Dennis RA,Huang J,Reeder J,Ricke WA

    更新日期:2011-01-01 00:00:00

  • Combination of 5-fluorouracil and cyclophosphamide in L1210 and P388 leukemias with changes in optimum treatments as a function of the age of the L1210 tumor at first treatment.

    abstract::The interaction of 5-fluorouracil and cyclophosphamide in the treatment of L1210 and P388 leukemias was studied using response surface methodology. Single dose treatment of each drug was administered simultaneously or with a 24-hr interval between 5-fluorouracil and cyclophosphamide to the advanced tumors or at variou...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357908709020311

    authors: Wampler GL,Carter WH Jr,Campbell ED

    更新日期:1987-01-01 00:00:00

  • Single agent vinflunine in the salvage treatment of patients with castration-resistant prostate cancer: a phase II trial of the Sarah Cannon research consortium.

    abstract::Patients with metastatic prostate cancer resistant to hormones and docetaxel were treated with vinflunine (320 mg/m(2) every 21 days), a new vinca alkaloid with improved preclinical activity. Only 1 of 36 patients (3%) had partial response; the median progression-free survival (PFS) was 2.1 months. Treatment was well ...

    journal_title:Cancer investigation

    pub_type: 杂志文章,多中心研究

    doi:10.3109/07357900902918460

    authors: Hainsworth JD,Meluch AA,Lane CM,Spigel DR,Burris HA 3rd,Gandhi JG,Crane EJ,Stipanov MA,Greco FA

    更新日期:2010-03-01 00:00:00

  • Loss of heterozygosity at the 9p21-24 region and identification of BRM as a candidate tumor suppressor gene in head and neck squamous cell carcinoma.

    abstract::We have analyzed allelic loss of the short arm of chromosome 9 in 39 head and neck cancers using 13 polymorphic markers and found two deletions of hot spots at 9p21 and 9p24. Loss of heterozygosity was detected at least at one locus in 28 of 39 cases (71.8%). P16, a well-known tumor suppressor gene, is considered to b...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900802563010

    authors: Gunduz E,Gunduz M,Ali MA,Beder L,Tamamura R,Katase N,Tominaga S,Yamanaka N,Shimizu K,Nagatsuka H

    更新日期:2009-07-01 00:00:00

  • Evaluation of drug delivery and survival impact of dose-intense relative to conventional-dose methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy in urothelial cancer.

    abstract::The efficacy of dose-intense methotrexate, vinblastine, doxorubicin, and cisplatin (M-VAC) chemotherapy relative to conventional-dose M-VAC in patients with advanced transitional cell carcinoma is unknown. The outcomes of 33 patients on two successive protocols using dose-intense M-VAC with granulocyte colony-stimulat...

    journal_title:Cancer investigation

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.3109/07357900009032829

    authors: Dodd PM,McCaffrey JA,Mazumdar M,Scher H,Higgins G,Boyle MG,Herr H,Bajorin DF

    更新日期:2000-01-01 00:00:00

  • Trypsin-2 enhances carcinoma invasion by processing tight junctions and activating ProMT1-MMP.

    abstract::Enhanced proteolysis and altered tight junction (TJ) proteins associate with carcinoma invasion. We hypothesized that trypsin-2, a tumor-associated serine proteinase, induces tongue carcinoma invasion by activating pro-membrane type-1 matrix metalloproteinase (MT1-MMP) and disturbing the TJs. The effects of invasion w...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2012.716467

    authors: Vilen ST,Suojanen J,Salas F,Risteli J,Ylipalosaari M,Itkonen O,Koistinen H,Baumann M,Stenman UH,Sorsa T,Salo T,Nyberg P

    更新日期:2012-10-01 00:00:00

  • Ammonium sulfate fractionation and assay of hormone receptors.

    abstract::Ammonium sulfate (AS) precipitation by consecutive steps at 10% to 50% saturation has been utilized for fractionation of cytoplasmic estrogen receptor (ER) and progesterone receptor (PgR). The highest percentage of both receptor activities are confined mainly in two fractions at AS saturation from 20% to 30% and 30% t...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357908909039842

    authors: Chen YM,Vaughn CB

    更新日期:1989-01-01 00:00:00

  • Chromosome breaks and genomic instability.

    abstract::Tumorigenesis is known to result from multiple genetic changes. Although endogenous and environmental insults can damage DNA, cellular mechanisms exist to repair various forms of damage or to kill those cells irreparably damaged. Hence, the accumulation of numerous genetic changes that would lead to cancer in normal c...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.3109/07357900009023065

    authors: Jasin M

    更新日期:2000-01-01 00:00:00

  • A pilot study of predictive markers of chemotherapy-related amenorrhea among premenopausal women with early stage breast cancer.

    abstract:BACKGROUND:Premenopausal women treated for early stage breast cancer (ESBC) are at risk for chemotherapy-related amenorrhea (CRA). Prospectively-validated, predictive markers of CRA are needed. PATIENTS AND METHODS:Premenopausal women with ESBC and planned chemotherapy (>/= 25% risk of amenorrhea) were evaluated. Foll...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900701829777

    authors: Anders C,Marcom PK,Peterson B,Gu L,Unruhe S,Welch R,Lyons P,Behera M,Copland S,Kimmick G,Shaw H,Snyder S,Antenos M,Woodruff T,Blackwell K

    更新日期:2008-04-01 00:00:00

  • Does routine clinical practice reproduce the outcome of large prospective trials? The analysis of institutional database on patients with limited-disease small-cell lung cancer.

    abstract::We performed the analysis of database on 409 patients with LD-SCLC to evaluate as to what extent the clinical outcome of large prospective trials was reproduced in routine practice. The analysis has shown that the hazard rate of death in the absence of prophylactic cranial irradiation (PCI) adjusted for the effects of...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2013.861470

    authors: Wzietek I,Suwinski R,Nowara E,Bialas M,Bentzen S,Tukiendorf A

    更新日期:2014-01-01 00:00:00

  • Could concomitant radio-chemotherapy improve the outcomes of early-stage node negative anal canal cancer patients? A retrospective analysis of 122 patients.

    abstract::One hundred twenty-two early-stage anal canal cancer patients (median age: 69 years) were treated with curative radiotherapy with (70 patients) or without (52 patients) concomitant chemotherapy. Median follow-up was 65 months (range: 4-238). At multivariate analysis, concomitant chemotherapy significantly improved loc...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2014.1001898

    authors: De Bari B,Lestrade L,Pommier P,Maddalo M,Buglione M,Magrini SM,Carrie C

    更新日期:2015-04-01 00:00:00

  • Lifestyle factors, exposures, genetic susceptibility, and renal cell cancer risk: a review.

    abstract::Malignant kidney tumors account for approximately 2% of all new primary cancer cases diagnosed in the United States, with an estimated 30,000 cases occurring annually. Although a variety of agents, chemical and biological, have been implicated as causal agents in the development of renal cell carcinoma (RCC), the etio...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1081/cnv-200055962

    authors: Moore LE,Wilson RT,Campleman SL

    更新日期:2005-01-01 00:00:00

  • A thousand points of light or just dim bulbs? Radiolabeled antibodies and colorectal cancer imaging.

    abstract::Radioimmunoscintigraphy (RIS) is coming into its own as an imaging modality in clinical oncology. Early experience with indium-111-labeled intact murine monoclonal antibodies (MoAbs) in colorectal cancer suggested that RIS images hepatic metastases poorly. Moreover, an antimurine immune response was frequently provoke...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.3109/07357909909032874

    authors: Moffat FL Jr,Gulec SA,Serafini AN,Sfakianakis GN,Pop R,Robinson DS,Franceschi D,Boggs J,Livingstone AS

    更新日期:1999-01-01 00:00:00

  • Cells of chemically induced tumors differentially express major histocompatibility complex class I antigens.

    abstract::Several recent studies have indicated that alterations in expression of major histocompatibility complex (MHC) antigens by tumor cells affects the ability of the host to mount an effective antitumor immune response. To investigate whether newly induced tumors frequently exhibit altered MHC antigen expression, we used ...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357909109021324

    authors: Reagan WJ,Pardi D,Callahan GN

    更新日期:1991-01-01 00:00:00

  • Molecular mechanisms linking endometriosis under oxidative stress with ovarian tumorigenesis and therapeutic modalities.

    abstract::Inflammation plays a role in the pathogenesis of endometriosis. Endometriosis-associated ovarian carcinogenesis might be promoted through oxidative stress-induced increased genomic instability, aberrant methylation, and aberrant chromatin remodeling, as well as mutations of tumor suppressor genes. Aberrant expression ...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.3109/07357907.2012.681821

    authors: Shigetomi H,Tsunemi T,Haruta S,Kajihara H,Yoshizawa Y,Tanase Y,Furukawa N,Yoshida S,Sado T,Kobayashi H

    更新日期:2012-07-01 00:00:00

  • "Conflict-of-interest" and participation in IRB deliberations: an alternative perspective.

    abstract::A natural tension exists as an IRB attempts of fulfill its mission of providing an independent and unbiased evaluation of a study while also insuring appropriate consideration of all relevant risks, benefits, and alternative strategies. IRB members with often critically relevant knowledge of unique issues involved in ...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1080/07357900701579562

    authors: Markman M

    更新日期:2008-03-01 00:00:00

  • Comparison of the expression of P-glycoprotein, Ki-67, and P-53 to technetium-99m tetrofosmin mammoscintigraphic findings.

    abstract::Adjuvant and neoadjuvant chemotherapy is being used increasingly in the treatment of breast cancer patients. However, drug resistance plays an important role in the failure of chemotherapy in breast cancer. The aim of this study was to compare technetium-99m tetrofosmin (Tc-TETRO) mammoscintigraphic findings with the ...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1081/cnv-120001147

    authors: Liu TJ,Tsai SC,Ho YJ,Sun SS,Kao CH

    更新日期:2002-01-01 00:00:00

  • A phase II study of single agent bortezomib in patients with metastatic breast cancer: a single institution experience.

    abstract::PS-341, now known as bortezomib (Velcade[Millenium Pharmaceuticals, Inc., Cambridge, MA; and Johnson & Johnson Pharmaceutical Research & Development, LLC, Spring house, PA]), is a proteasome inhibitor approved for the treatment of refractory multiple myeloma. Preclinical and early clinical studies showed PS-341 to be ...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900701506573

    authors: Engel RH,Brown JA,Von Roenn JH,O'Regan RM,Bergan R,Badve S,Rademaker A,Gradishar WJ

    更新日期:2007-12-01 00:00:00